Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience

References

• Buskirk SJ, Evans RG, Banks PM, O'Connell MJ, Earle JD. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys 1982;8:1699–1703.
   PubMed Web of Science ®Google Scholar
• Sussman EB, Hajdu SI, Lieberman PH, Whitmore WF. Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. J Urol 1977;118:1004–1007.
   PubMed Web of Science ®Google Scholar
• Read G. Lymphomas of the testis – results of treatment 1960–77. Clin Radiol 1981;32:687–692.
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727–737.
   PubMed Web of Science ®Google Scholar
• Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252–260.
   PubMed Web of Science ®Google Scholar
• Otter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989;25:1203–1210.
   PubMedGoogle Scholar
• Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994;30A:1760–1764.
   PubMed Web of Science ®Google Scholar
• Tweed CS, Peck RJ. A sonographic appearance of testicular lymphoma. Clin Radiol 1991;43:341–342.
   PubMed Web of Science ®Google Scholar
• Verma N, Lazarchick J, Gudena V, Turner J, Chaudhary UB. Testicular lymphoma: an update for clinicians. Am J Med Sci 2008;336:336–341.
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Mughal TI, et al Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003;21:20–27.
   PubMed Web of Science ®Google Scholar
• Salem YH, Miller HC. Lymphoma of genitourinary tract. J Urol 1994;151:1162–1170.
   PubMed Web of Science ®Google Scholar
• Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994;18:376–390.
   PubMed Web of Science ®Google Scholar
• Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases. Mod Pathol 2006;19:1521–1527.
   PubMed Web of Science ®Google Scholar
• Miedler JD, MacLennan GT. Primary testicular lymphoma. J Urol 2007;178:2645.
   PubMed Web of Science ®Google Scholar
• Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc 2007;99:1277–1282.
   PubMed Web of Science ®Google Scholar
• Shahab N, Doll DC. Testicular lymphoma. Semin Oncol 1999;26:259–269.
   PubMed Web of Science ®Google Scholar
• Pectasides D, Economopoulos T, Kouvatseas G, et al Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the Hellenic Cooperative Oncology Group experience. Oncology 2000;58:286–292.
   PubMed Web of Science ®Google Scholar
• Fonseca R, Habermann TM, Colgan JP, et al Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000;88:154–161.
   PubMed Web of Science ®Google Scholar
• Crellin AM, Hudson BV, Bennett MH, Harland S, Hudson GV. Non-Hodgkin's lymphoma of the testis. Radiother Oncol 1993;27:99–106.
   PubMed Web of Science ®Google Scholar
• Ciatto S, Cionini L. Malignant lymphoma of the testis. Acta Radiol Oncol Radiat Phys Biol 1979;18:572–576.
   PubMed Web of Science ®Google Scholar
• Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med 1986;81:515–524.
   PubMed Web of Science ®Google Scholar
• Visco C, Medeiros LJ, Mesina OM, et al Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy? Clin Lymphoma 2001;2:40–46.
   PubMedGoogle Scholar
• Duncan PR, Checa F, Gowing NF, McElwain TJ, Peckham MJ. Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases. Cancer 1980;45:1578–1584.
   PubMed Web of Science ®Google Scholar
• Touroutoglou N, Dimopoulos MA, Younes A, et al Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995;13:1361–1367.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112–2135.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
   Google Scholar
• Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
   Google Scholar
• Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860–1861.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, et al Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
   PubMed Web of Science ®Google Scholar
• Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• Cox D. Regression models in life tables. J R Stat Soc 1972;B34:187–220.
   Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Horstmann WG, Timens W. Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour. Virchows Arch 1996;429:83–90.
   PubMed Web of Science ®Google Scholar
• Riemersma SA, Jordanova ES, Schop RF, et al Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 2000;96:3569–3577.
   PubMed Web of Science ®Google Scholar
• Haioun C, Besson C, Lepage E, et al Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte. Ann Oncol 2000;11:685–690.
   PubMed Web of Science ®Google Scholar
• Aviles A, Nambo MJ, Cleto S, Neri N, Huerta-Guzman J. Rituximab and dose-dense chemotherapy in primary testicular lymphoma. Clin Lymphoma Myeloma 2009;9:386–389.
   PubMedGoogle Scholar